Jan 16, 2014

State Administration of Ukraine on Medicinal Products (SAUMP) permitted Farmak JSC to resume circulation of the medicinal products

Based on the positive results of the quality investigation as regards the medicinal products manufactured by Farmak JSC, SAUMP permitted to resume circulation of Farmak medicinal products.

According to the orders issued by SAUMP, it is permitted to resume circulation (sale and usage) of the following medicinal products:

FLENOX®, solution for injections;
CORVALOL®, oral drops;
CORVALOL® N, oral drops;
URONEPHRON®, gel;
CORVALOL®, tablets in blisters;
CORVALDIN®, oral drops;
NAZOFERON®, nasal drops in glass vials (batches 301113, 321113, 271013, 140713, 210913, 180813);
NAZOFERON®, nasal spray in glass vials (batches 251113, 261113, 281113, 140913, 291113, 271113).

Back to the News

Previous Next

More news

Farmak exhibited its line of medicines in International...

The leader of the Ukrainian pharmaceutical market*, Farmak participated in one of most prestigious global events of the pharmaceutical industry – CPHI 2024 on October 8-10, 2024, in Milan, Italy. This year, the exhibition united over 2400 exhibitors and 62 thousand visitors of over 166 countries of the world, as well as over 150 expert […]

Oct 18, 2024

A new Chief Financial Officer has joined Farmak

A leader in the Ukrainian pharmaceutical market*, Farmak has strengthened the top management with a new Chief Financial Officer. It is Mr Serhii Plichko, who has over 15 years of experience in finance, logistics, and operations. Mr Serhii Plichko will be responsible for the operation and improvement of the financial systems, the optimization of the […...

Oct 11, 2024

Farmak has been recognized the country’s best employer

Farmak, a leader in the Ukrainian pharmaceutical market*, was included in the TOP 50 Best Employers of Ukraine. The rating was prepared by NewVoice and Odgers Berndtson Ukraine, an international headhunter company specializing in search and appraisal of top managers. Farmak won in two nominations, in particular, Supporting Veterans and Their Families, and Su...

Oct 11, 2024